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Abstract 
Background: Chlamydia trachomatis infection is the most frequently reported notifiable 
disease in the United States and in Washoe County, Nevada.  This disease is associated with a 
variety of complications and sequelae, and these risks increase with repeated infections. 
Objective: To evaluate existing local data to identify risk factors associated with repeat 
Chlamydia trachomatis infections and make appropriate recommendations for prevention. 
Study Design: A retrospective study of patients reported with Chlamydia trachomatis infection 
from 1999 through 2008 included in the local application of the national STD surveillance 
system. 
Results: Among 9,551 unique cases diagnosed with Chlamydia trachomatis during the ten 
year surveillance period, 1,173 (12.3%) had repeat infections.  Females were more likely than 
males to have a repeat infection (odds ratio [OR] 1.8, 95% confidence interval [CI] 1.4, 2.4).  
Subjects less than 20 years of age and those 20 – 24 years of age were more likely than their 
older counterparts to have a repeat infection (OR 1.9, 95% CI 1.3, 2.6 and OR 1.5, 95% CI 1.1, 
2.1 respectively).  Subjects seen in STD Clinic settings (OR 1.6, 95% CI 1.2, 2.2)or by all other 
providers including drug treatment, other clinic, Job Corps, mental health or Indian Health 
Services (OR 1.4, 95% CI 1.0, 2.0) were more likely to develop a repeat infection than those 
seen in other settings.  Repeat infection was not associated with race/ethnicity, length of time 
from diagnosis to treatment, treatment regimen, a history of multiple sexual partners; any 
acknowledged risk or a history of sex with males. 
Conclusions: Repeat infection was relatively common among this population.  The results of 
this study support more frequent screening of sexually active females, all sexually active 
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persons less than 25 years of age, all persons seen in an STD clinic, and any person with a prior 
history of a sexually transmitted disease.  Missing risk factor data on more than one-third of 
study subjects suggest the need for a more comprehensive review of available risk factor data, 
perhaps through the use of the electronic medical record used in the STD clinic.  Implementing 
a patient reminder system to return to the clinic for rescreening using new and innovative 
methods of communication such as email or text messages may help to identify repeat 
infections earlier and reduce the burden of disease.  Additional prevention opportunities 
include increased staff for disease investigation, enhanced public education utilizing new forms 
of communication and social marketing, implementation of partner therapy and streamlined 
testing protocols, and a shift in focus to primary prevention. 
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Introduction 
Chlamydia is a sexually transmitted disease (STD) caused by the bacterium, Chlamydia 
trachomatis (1) for which humans are the only reservoir. (2)  Although poorly defined, the 
incubation period is thought to be seven to fourteen days or longer. (2)  In males the sexually 
transmitted genital infection presents as urethritis with symptoms including mucopurulent 
discharge, urethral itching and burning on urination, while in females infection presents in the 
cervix and results in mucopurulent endocervical discharge. (2)  Infection is asymptomatic in up 
to 25% of males and up to 70% of females. (2) 
Chlamydia can result in a variety of complications and sequelae, including pelvic 
inflammatory disease (PID), a major cause of infertility, ectopic pregnancy and chronic pelvic 
pain. (2; 3)  Complications of infection during pregnancy include premature rupture of 
membranes resulting in preterm delivery as well as passing the infection to the newborn in the 
form of ophthalmia and pneumonia. (2)  Less common complications include “Bartholinitis, 
urethral syndrome with dysuria and pyuria, perihepatitis (Fitz-Hugh-Curtis syndrome) and 
proctitis.” (2)  Additionally, Chlamydia infection is known to facilitate Human Immunodeficiency 
Virus (HIV) infection transmission, as are other inflammatory STDs. (3) 
Diagnosis of urethral Chlamydia infection in males is performed by testing a urethral 
swab or urine specimen; in females a urine specimen or swab collected from the endocervix or 
vagina is tested. (4)  Rectal swabs can also be tested for persons who participate in receptive 
anal intercourse. (4)  Multiple tests are available for the detection of C. trachomatis including 
culture, direct immunofluorescence, enzyme immune-assay (EIA), nucleic acid hybridization 
tests, and nucleic acid amplification tests (NAATs). (4)  Increasingly sensitive diagnostic tests are 
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one of the factors contributing to the increase in reported Chlamydia infections in the past 20 
years. (3) 
Chlamydial infections not only comprise the largest proportion of all STDs reported to 
the Centers for Disease Control and Prevention (CDC) but are also the most frequently reported 
notifiable disease in the United States. (3)  In 2008 there were over 1.2 million chlamydial 
infections reported to CDC, corresponding to a rate of 401.3 cases per 100,000 population.  This 
figure represented a 9.2% increase over the rate seen in 2007.  The national rate per 100,000 
population has increased from 102.5 in 1989 to 402.3 in 2008, an increase of 292%.  (3) 
Chlamydial infections are also the most frequently reported notifiable disease in 
Washoe County.  In Washoe County, between 796 and 1509 cases of Chlamydia have been 
reported annually between 1999 and 2008.  The 2008 rate per 100,000 population was 316, a 
27 percent increase from the 1999 rate of 248 (Figure 1).  The highest rate occurred in 2007 at 
361 reported cases per 100,000 population (Washoe County, unpublished data, 2008). 
Figure 1.  Rate of reported Chlamydia cases, Washoe County, Nevada, 1999-2008. 
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Washoe County, unpublished data, 2008. 
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Repeat Chlamydia infection is associated with increased risk of sequelae, including 
ectopic pregnancy and pelvic inflammatory disease (PID), when compared with the initial 
infection. (4; 5)  CDC does not recommend repeat testing for cure three to four weeks after 
completing therapy due to the effectiveness of recommended regimens and the potential for 
false positive test results.  However, due to the complications associated with repeat Chlamydia 
infection and the fact that most post treatment infections are the result of sex with untreated 
partners or new partners, CDC does recommend that all women with chlamydial infection be 
retested 3 months after treatment, or at the next medical visit occurring within 3 – 12 months 
of the initial infection. (4)   
Although various studies currently exist in the literature examining repeat Chlamydia 
infection, many of these studies focus on a particular clinical setting, such as STD clinics (6; 7; 8; 
9; 10; 11), or a particular segment of the population such as adolescents (12), females (13; 14; 
15), or persons serving in the military (16).  Few studies exist that examine comprehensive 
population-based data from STD registries (17; 18).  An extensive analysis of local level data in 
Washoe County has not previously been performed.  However, a preliminary analysis 
conducted in 2005 did recommend that additional studies should be undertaken (Washoe 
County, unpublished data, 2005).  The purpose of this study was to evaluate existing local data 
to identify risk factors for repeat Chlamydia trachomatis infection and make appropriate 
recommendations for prevention. 
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Methods 
Data Source 
Chlamydia trachomatis infection of the genital tract has been a reportable condition in 
the state of Nevada since 1992. (19)  Laboratories, health care providers, and medical facilities 
are required to report laboratory-confirmed chlamydial infections to the local health authority 
within one business day. (19)  Washoe County Health District is the local health authority for 
the county of Washoe, which consists of the cities of Reno and Sparks in northern Nevada.  The 
estimated population of Washoe County in 2008 was 423,833. (20)  Cases reported are referred 
to one of two Disease Intervention Specialists (DISs) for investigation to confirm the diagnosis, 
identify contacts, and ensure that the case and any identified contacts have received 
appropriate testing and treatment. (19)  All cases are entered by the DISs into a database called 
STD*MIS.  STD*MIS is a voluntary application provided to state and local health departments by 
CDC to facilitate the management of data received from laboratories, health care providers, 
clinics, etc.  It also allows for the transmission of “non-named case morbidity data” to be 
transmitted to CDC. (21)  Data for this study was obtained from the local application of 
STD*MIS. 
Definitions 
A repeat infection was defined as a Chlamydia trachomatis infection detected greater 
than thirty days after appropriate treatment of a previous infection.  Treatment was considered 
appropriate if it was consistent with the current CDC recommendations that were available at 
the time of diagnosis. (4; 22; 23)  The thirty-day interval was measured from the date on which 
the initial infection was treated to the date of testing for the subsequent or “repeat” infection.  
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The thirty-day minimum interval was used due to the possibility of false-positive results with 
some diagnostic tests (including nucleic acid amplification tests or NAATs) when performed less 
than three weeks after successful treatment. (4)  For persons with multiple repeat infections, 
only the first repeat infection was included in the final data set, all subsequent repeat infections 
as well as the initial infection for these subjects were excluded from the final data set employed 
for further analysis.  
Statistical Methods 
Data was exported from STD*MIS into four separate Excel files:  laboratory module, 
morbidity module, treatment module and risk module.  The Excel files were then de-identified.  
The laboratory, morbidity and treatment modules were imported into PASW Statistics 17.0 
(SPSS Inc., Chicago, IL) and linked by patient ID and event ID.  This main database was reviewed 
to identify infections as repeat or non-repeat infections.  The risk module was imported into 
PASW Statistics 17.0 and restructured so that there was only one row per event, with the risk 
factors listed in columns.  Finally, the risk data was linked with the main data in PASW Statistics 
17.0 to create the final database for analysis.  All statistical analyses were completed using 
PASW Statistics 17.0.  Bivariate analysis was performed to assess the association between 
outcome variable and the different indicator variables.  Chi-square was used except when a 
cell’s expected value was smaller than five in which case Fisher’s exact test was used.  All 
variables with a p value of 0.10 or less were included in the binary logistic regression for the 
final association magnitude assessment and reporting. 
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Results 
Between 1999 and 2008, a total of 11,743 episodes of urogenital chlamydial infection 
were reported to the Washoe County Health District.  Of these 11,743 episodes, 9,551 unique 
cases remained in the final cohort for analysis after excluding 1,173 initial infections for persons 
with more than one infection, 532 subsequent infections for persons with more than one 
repeat infection, and 487 infections that were either too close to a previous infection to be 
counted as a repeat case (i.e. thirty days or less), or were one of more than one episode for a 
case but were either not treated, or were not treated with one of the CDC recommended 
treatment regimens.  The annual rate of reported Chlamydia cases ranged from 196 to 324 
cases per 100,000 population (Figure 2).  The rates in Figure 2 will be slightly lower than those 
shown in Figure 1 because Figure 2 represents unduplicated subjects. The rate in 1999 was the 
lowest at 196 cases per 100,000 population.  In 2008 the rate decreased from its peak in 2007 
of 324 to 294 cases per 100,000 population. 
Figure 2.  Rate of reported unduplicated Chlamydia cases, Washoe County, Nevada, 1999-2008. 
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Note: Data will differ slightly from locally reported data due to deduplication in the data set used for final 
analysis. 
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Table 1. Characteristics of subjects, adjusted odds ratio (OR) and 95% confidence interval (CI) for 
indicators of repeat Chlamydia infection (N = 9,551), Washoe County, Nevada, 1999-2008. 
N % n n/N (%)
Tota l 9551 1173 12.3
Gender
     Female 5954 62.3 807 13.6 1.84 1.40, 2.43**
     Male 3579 37.5 332 9.3
Race/Ethnici ty
     American Indian/Alaskan Native 294 3.1 43 14.6 1.29 0.80, 2.08
     As ian/Paci fic Is lander 530 5.5 62 11.7 0.87 0.59, 1.29
     Black 1234 12.9 184 14.9 0.89 0.69, 1.16
     Hispanic 2899 30.4 339 11.7 1.02 0.84, 1.25
     Other/Unknown 110 1.2 27 24.5 0.65 0.23, 1.88
     White 4484 46.9 502 11.2
Age Group (in years)
     < 20 3485 36.5 446 12.8 1.86 1.33, 2.59**
     20 - 24 3522 36.9 436 12.4 1.48 1.07, 2.06*
     25 - 29 1449 15.2 158 10.9 1.12 0.77, 1.63
     > 29 1053 11.0 94 8.9
Provider Type
     Fami ly Planning 1145 12.0 152 13.3 1.39 0.99, 1.94
     Hos pita l/Emergency Department 523 5.5 46 8.8 1.17 0.74, 1.84
     Ja i l /Corrections 523 5.5 80 15.3 1.45 0.92, 2.27
     Reproductive Health 1153 12.1 132 11.4 1.14 0.81, 1.62
     STD
§
 Cl inic 2945 30.8 388 13.2 1.62 1.19, 2.21**
     Al l  Other Providers
§
1257 13.2 174 13.8 1.43 1.02, 2.00*
     Private Phys ician/HMO
§
1963 20.6 162 8.3
Tes t Type
     CT NAAT
§
4519 47.3 616 13.6 1.49 1.18, 1.89**
     CT Other
§
394 4.1 35 8.9 1.51 0.85, 2.67
     CT DNA Probe
§
4596 48.1 483 10.5
Diagnosis  to Ini tiation of Treatment
     4 - 7 Days 1410 14.8 204 14.5 1.23 0.97, 1.56
     > 7 Days 886 9.3 125 14.1 1.27 0.95, 1.71
     < 3 Days 7237 75.8 810 11.2
Treatment
     Doxycyl ine 857 9.0 93 10.9 1.35 0.98, 1.85
     Other 73 0.8 7 9.6 1.95 0.81, 4.66
     Azi thromycin 8344 87.4 1020 12.2
Multiple Partners
     Yes 1071 11.2 166 15.5 0.96 0.68, 1.35
     No 4851 50.8 609 12.6
History of STD Diagnosis
     Yes 921 9.6 716 77.7 305.09 223.40, 416.66**
     No 5001 52.4 59 1.2
Any Ris k
     Yes 5414 56.7 766 14.1 1.45 0.61, 3.44
     No 508 5.3 9 1.8
Sex with Male
     Yes 3604 37.7 543 15.1 0.89 0.61, 1.28
     No 2318 24.3 232 10.0
Reference
Reference
Reference
Reference
Reference
Reference
Reference
§
 OR, odds ratio; CI, confidence interval; STD, sexually transmitted disease; All Other Providers: Drug Treatment, Other Clinic, Job Corps,
Mental Health, Indian Health Services, Other; HMO, health maintenance organization; CT NAAT, Chlamydia trachomatis nucleic acid
amplification test; CT Other, Chlamydia trachomatis Other includes culture & PCR; CT DNA Probe, Chlamydia trachomatis DNA probe.
* p  < 0.05; ** p  < 0.01
Reference
Reference
Reference
Al l
cases
Cas es  with >1
repeat infection OR
§
95% CI
§
Reference
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Characteristics for all subjects in the final data set are included in Table 1.  All 
characteristics were measured at the time of the included infection.  The median age of all 
cases was 21 years with 37 percent of cases less than 20 and 37 percent between 20 and 24 
years of age.  The median age of repeat cases was also 21 years.  Sixty-two percent of all cases 
were female; 47 percent were white, non-Hispanic.  Almost half (48.3%) of all cases were seen 
in publicly funded clinics, including STD clinics, family planning clinics, HIV testing sites, and 
jail/correctional settings.  Ninety-five percent of cases were tested with either CT DNA probe or 
CT NAAT.  The majority of cases (87%) were treated with azithromycin and most cases (76%) 
were treated within three days of diagnosis. 
In the final data set 12.3 percent of cases (1173 of 9551) were repeat infections.  Of 
demographic characteristics, only gender and age were statistically significant associated with 
repeat infection after adjusting for the confounding effects from other variables, including 
race/ethnicity, provider type, test type, length of time from diagnosis to treatment, multiple 
partners, history of STD diagnosis, any acknowledged risk and sex with males.  Females were 
more likely than males to have a repeat infection (odds ratio [OR] 1.8, 95% confidence interval 
[CI] 1.4, 2.4).  Subjects less than 20 years of age and those 20 – 24 years of age were more likely 
than their older counterparts to have a repeat infection (OR 1.9, 95% CI 1.3, 2.6 and OR 1.5, 
95% CI 1.1, 2.1 respectively).  Other/unknown race ethnicity saw the highest rate of repeat 
infection at 24.5 percent, followed by Blacks at 14.9 percent and American Indian/Alaskan 
Native at 14.6 percent.  The remaining groups were similar with Asian/Pacific Islander and 
Hispanics at 11.7 percent and whites at 11.2 percent; however, race/ethnicity was not a 
statistically significant indicator. 
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Provider type was statistically significant associated with repeat infection after adjusting 
for the confounding effects from other variables including age group, gender, race/ethnicity, 
test type, length of time from diagnosis to treatment, multiple partners, history of STD 
diagnosis, any acknowledged risk and sex with males.  Subjects seen at an STD Clinic (OR 1.6, 
95% CI 1.2, 2.2) or at All Other Providers including drug treatment, other clinic, Job Corps, 
mental health or Indian Health Services (OR 1.4, 95% CI 1.0, 2.0) were more likely to develop a 
repeat infection than those seen in other settings.  Although subjects seen in jail/corrections 
had the highest rate of repeat infection at 15.3 percent, this was not statistically significant. 
Test type was statistically significant associated with repeat infection after adjusting for 
the confounding effects from other variables including age group, gender, race/ethnicity, 
provider type, length of time from diagnosis to treatment, multiple partners, history of STD 
diagnosis, any acknowledged risk and sex with males.  Subjects tested by nucleic acid 
amplification were more likely to have a repeat infection (OR 1.5, 95% CI 1.2, 1.9) than those 
tested by other methods. 
An obvious statistically significant indicator was that of a prior history of STD diagnosis.  
After adjusting for the confounding effects from other variables including age group, gender, 
race/ethnicity, test type, provider type, length of time from diagnosis to treatment, multiple 
partners, any acknowledged risk and sex with males, subjects with a history of STD diagnosis 
were more likely than those without to develop a repeat infection (OR 305.1, 95% CI 223.4, 
416.7).  Sexual behavior, specifically history of multiple partners, any acknowledged risk or sex 
with male, was not associated with repeat infection in multivariate analysis.  All statistically 
significant indicators with the exception of history of STD diagnosis are plotted in Figure 3. 
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Figure 3.  Adjusted odds ratio (OR) and 95% confidence interval (CI) for indicators of repeat Chlamydia 
infection, Washoe County, Nevada, 1999-2008. 
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The yearly rate of repeat infection for all cases ranged from 3.6 to 14.1 percent (Figure 
4).  Males ranged from 2.6 to 11.4 percent while females ranged from 4.0 to 16.2 percent.  
Almost one-third (30.5%) of cases with repeat infection were diagnosed within six months of 
the initial infection (Table 2).  The median length of time between initial and repeat infection 
was 11.5 months (range 1 month to 9 years).  The total number of reported infections per 
subject as shown in Table 3 ranged from two (942 subjects) to seven (one subject). 
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Figure 4.  Percent of repeat Chlamydia infections by year and gender, Washoe County, Nevada, 1999-
2008. 
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Table 2.  Time from initial Chlamydia infection to first repeat infection, Washoe County, Nevada, 1999-
2008. 
Time between initial
& 1st repeat infection
# of Repeat
Infections
% of Repeat
Infections
% of all Cases
< 6 months 358 30.5 3.7
6 - 18 months 392 33.4 4.1
> 18 months 423 36.1 4.4
Total 1173 100.0 12.3  
Table 3.  Total number of repeat Chlamydia infections, Washoe County, Nevada, 1999-2008. 
Total # of Infections
# of Repeat
Infections
% of Repeat
Infections
% of all Cases
2 942 80.3 9.9
3 182 15.5 1.9
4 34 2.9 0.4
5 10 0.9 0.1
6 4 0.3 0.0
7 1 0.1 0.0
Total 1173 100.0 12.3  
Also of note is the shift from DNA probe testing to nucleic acid amplification testing for 
Chlamydia trachomatis (Figure 5).  In 1999, only 11 percent of cases were identified through 
nucleic acid amplification testing while 89 percent of cases were identified through DNA probe 
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testing.  By 2008, nucleic acid amplification testing had increased to 68 percent, while DNA 
probe testing had decreased to 29 percent. 
Figure 5.  Test type for Chlamydia cases represented as percent of total cases, Washoe County, 
Nevada, 1999-2008. 
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CT NAAT: Chlamydia trachomatis nucleic acid amplification test 
CT DNA:  Chlamydia trachomatis DNA probe 
CT Other: Chlamydia trachomatis culture and Chlamydia trachomatis PCR 
Discussion 
This study demonstrated a substantial increase in rate of Chlamydia trachomatis 
infections during the ten year surveillance period.  The 1999 rate of 196 cases per 100,000 
population increased to 294 cases per 100,000 population in 2008, an increase of 50 percent.  
This increase is similar to that seen at the national level. (3)  As with the national level data, 
there are a number of possible explanations for this increase, including expansion of Chlamydia 
screening activities, use of more sensitive tests and more complete reporting. (3)  Annual 
screening of all sexually active women under 26 years of age and women over 25 with risk 
factors as is currently recommended by CDC (4) contributes to increased screening for this 
infection in females.  Although similar CDC guidelines for screening of sexually active males do 
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not currently exist (4), the increased availability of urine testing for this infection has resulted in 
increasing numbers of men being tested for Chlamydia as well. (3)  The new generation of 
molecular diagnostic STD tests provides superior performance without being invasive (12), and 
has improved sensitivity.  Both the increased emphasis on provider and laboratory reporting 
and the advancements in the information systems used for reporting have also contributed to 
the increase in rate. Finally, the increase in incidence of Chlamydia trachomatis in Washoe 
County may reflect a true increase in morbidity for this infection, as is suspected with national 
level data. (3) 
The overall repeat Chlamydia trachomatis infection rate for this study was 12.3 percent; 
slightly higher for females at 13.6 percent and lower for males at 9.3 percent.  This overall rate 
of 12.3 percent is comparatively lower than that seen in several previous studies which ranged 
from 13.4 to 16.4 percent. (12; 13; 18)  This is understandable given the passive nature of this 
study, as subjects were not required to return at specific intervals for repeat testing as with 
some prospective studies.  However, this rate is also higher than that seen in multiple other 
previous studies which ranged from 7.5 to 11.9 percent. (9; 11; 16; 24; 25)  Since this study 
used ten years of surveillance data it afforded a longer follow up period than that of most 
studies, providing more time for subjects to be reinfected.  In addition, limitations were not 
placed on the time from initial to repeat infection as in some previous studies.   
The magnitude of association between age group and repeat infection is smaller in this 
study than that found in a similar study conducted by Xu et al. using Washington state 
surveillance data from 1993 to 1998. (17)  Xu et al. found that females aged 10-14 years were 
6.3 times more likely to develop at least one repeat infection and females 15-19 years were 3.5 
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times more likely to develop a repeat infection compared to females 30-44 years of age.  
Although the present study found subjects less than 20 years of age more likely to develop 
repeat infection when compared with subjects 30 years of age and older, the magnitude of that 
association was only 1.9.  This difference in strength of association is likely due to differences in 
study design.  While the present study analyzed characteristics at the time of the included 
infection, in the Washington study all characteristics with the exception of clinic type were 
measured at the time of the initial infection. (17)  It may also be that this variation in magnitude 
is the result of differences in the populations under surveillance. 
A surprising finding was that behavioral risk factors such as history of multiple partners, 
any acknowledged risk and sex with males were not associated with development of repeat 
Chlamydia trachomatis infection.  However, this finding is most likely related to the fact that 
risk factor data was missing for 38 percent of cases in the cohort (3629/9551). 
The key strengths of this study are related to the source of data.  Using readily available 
surveillance data allowed for a long study period of ten years as well as provided population-
based data.  As stated by Xu et al., studies that are limited to specific clinic-based settings may 
underestimate the frequency of repeat infection, since women change their source of care 
regularly. (17)  This study included all clinical settings where Chlamydia trachomatis was 
diagnosed, including both the public and private sector. 
This study has several limitations.  Since the data source consisted of previously 
collected surveillance data, it was passive in nature and there was no active follow up effort.  
Subjects were not recruited and followed up at predetermined intervals for rescreening.  
Instead, it was dependent on the subject to seek care and the health care provider to perform 
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appropriate testing.  As with the Washington state study, the number of repeat Chlamydia 
infections may have been underestimated since repeat infections in subjects who moved out of 
Washoe County would have been missed.  Because the study was based on surveillance data, 
the reason for clinic visit was not available.  In addition, risk factor data was missing on more 
than one-third of cases.  Finally, it may have been helpful to use smaller age groups for analysis, 
for example 10-14, 15-19, 20-24, 25-29, and 30-44, as well as to have analyzed males and 
females separately. 
Recommendations 
The results of this study support more frequent screening of sexually active females, all 
sexually active persons less than 25 years of age, all persons seen in an STD clinic, and any 
persons with a prior history of a sexually transmitted disease.  However, since risk factor data 
was missing for more than one-third of cases in this study, additional studies of local level data 
should be taken.  Since those cases that were missing risk factor data in this study were likely 
those cases that were not interviewed by STD prevention and control staff, an analysis of STD 
clinic data from the electronic medical record used for documenting clinic visits at Washoe 
County Health District would provide a much more in-depth evaluation of potential risk factors. 
This additional analysis may help to refine the present recommendations further.  Building 
canned reports into the clinic database to enable the routine analysis of risk factors would 
provide real-time data to target prevention and control measures. 
A call-back system in which cases are reminded at three months and then again at six 
months post-infection (if no response to the first reminder) to return to the clinic for repeat 
screening would be beneficial, since currently there is no such system in place and it is 
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dependent on the patient to return on their own for follow-up.  Email addresses and cell phone 
numbers could be collected as part of the clinic visit and entered into the database.  Clients 
could be asked how they would prefer to receive reminder messages to return for follow-up 
appointments, with the understanding that the messages would be generic and not contain any 
confidential information.  Confidentiality issues would require that the patient’s name not be 
included in the message, that emails be sent from a generic address, and that the email itself 
not contain any protected health information.  A statement such as “Please contact us at 775-
328-2170 to schedule your next appointment” would be generic enough to not breach 
confidentiality but specific enough to convey the message.  Exploration of acceptable and 
effective methods for reminders should be explored with age-appropriate focus groups.  
Implementing a patient reminder system to return to the clinic for rescreening using new and 
innovative methods of communication may help to identify and treat repeat infections earlier, 
thereby decreasing the length of time individuals are infected and transmitting the disease to 
partners and ultimately reduce the burden of disease. 
The analysis and interpretation of local level data is just one tool in an effort to better 
understand the transmission of Chlamydial infections.  Many other opportunities exist to 
improve the prevention and control of this disease.  For example, only two Disease Intervention 
Specialists are responsible for investigating more than 1200 annual Chlamydia cases.  This is in 
addition to the gonorrhea and syphilis cases they are also responsible for, as well as providing 
coverage in the STD clinic.  Increased staff may help to identify and treat more cases and their 
contacts, thereby reducing disease burden.  Implementation of partner therapy and 
streamlined testing protocols to shorten clinic visits and reduce invasiveness of exams could be 
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explored to determine potential benefits.  Increased funding for public education campaigns to 
emphasize how common this disease is, the potential sequelae that result from infection such 
as PID, and to reinforce the asymptomatic nature and importance of screening may also be 
beneficial in reducing disease burden.  The rapid advancement of technology provides 
numerous new methods of communication which could be used to provide public health 
education regarding STDs.  Various social networking methods exist as well as traditional media 
forms such as television or radio through which social marketing campaigns could be launched.  
Although current budget restraints make the possibility of increased funding for staff and public 
education efforts unlikely, funding through acquisition of grants could be explored.  
Unfortunately, as with many diseases, to a great extent public health and health care efforts 
focus on treatment of the disease once it is diagnosed.  The focus needs to be shifted to 
primary prevention methods so that as much if not more effort is put into preventing the 
disease from occurring in the first place. 
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